10Mar
09Mar
Siamab Therapeutics Announces Publication of New Preclinical Data
Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced the publication of new preclinical data describing its novel ST1 antibodies targeting, with high affinity and specificity, the Sialyl-Thomasen-nouveau antigen (STn), a tumor-associated carbohydrate antigen (TACA). Read more >>
09Mar
Corbus Pharmaceuticals to Present Gene Expression Data from Recent Phase 2 Systemic Sclerosis Study Demonstrating JBT-101 Inhibits Inflammation and Fibrosis Pathways
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that Michael L. Whitfield, Ph.D., Professor of Molecular and Systems Biology, Dartmouth Geisel School of Medicine and Scientific Founder of Celdara Medical, LLC, will present data demonstrating JBT-101 treatment of systemic sclerosis patients inhibits gene expression of key regulatory proteins in molecular pathways associated with activating inflammation and fibrosis, while increasing gene expression in...
07Mar
Legally blind Flames fan watches game for first time
Olivia Lettich had been to a Calgary Flames game before, but she watched one for the very first time Sunday. The 11-year-old is legally blind, but thanks to eSight she was able to take in the sounds, and sights, of her favorite hockey team. Read more >>
04Mar
See That Smile
Forget virtual reality; Christian Cardenas is seeing in actual reality for the first time. “I can see you,” Christian told Jeff Fenton, marketing director for eSight, as he turned on Christian’s new eSight glasses. Christian was not shy about telling everyone Friday morning he could see them, and it was not just their shapes and voices registering. He was seeing them for the first time. Read more >>
02Mar
Skyline Medical Awarded Innovative Technology Contract from Vizient, Inc. for STREAMWAY® System
Skyline Medical Inc. (SKLN) (“Skyline” or “the Company”),producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal has received an Innovative Technology contract from Vizient, Inc. Read more >>
02Mar
Corbus Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference
Corbus Pharmaceuticals Holdings, Inc., a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that Yuval Cohen, Ph.D., Chief Executive Officer, will present at the Cowen and Company 37th Annual Health Care Conference on Wednesday, March 8 at 10:40 a.m. ET in Boston, MA. Read more >>
01Mar
Think pain relief without meds: sam® Sport shows adjunct, ultrasound therapy at APTA meeting Feb. 15-18
Patients can heal from chronic conditions and recover from pain faster – without the need for meds – through a simple, unique adjunct therapy: portable and wearable ultrasound. sam® Sport, made by ZetrOZ Systems, sustained acoustic medicine, will participate as a first-time exhibitor at the American Physical Therapy Association’s 2017 Combined Sections Meeting Feb. 15-18. Read more >>
01Mar
AR for the Blind
If you watched Star Trek in the 1980s and 1990s, you probably remember Geordi La Forge. He was blind but made use of a special visor placed over his eyes to see. A similar visor exists today. It is called “eSight”. This incredible technological innovation makes use of virtual reality as well as augmented reality. Specifically, the Geordie la Forge-esque eye visor uses camera screens and processors. Two screens are placed in front of the eyes to display images through...
28Feb